Cystic fibrosis | Healthy controls | |||||
r | r2 | p-value# | r | r2 | p-value# | |
SII | −0.52 | 0.27 | <0.001 | −0.04 | 0.00 | 0.764 |
Normalised SII | −0.44 | 0.20 | 0.002 | −0.01 | 0.00 | 0.912 |
SIII | −0.18 | 0.03 | 0.209 | 0.04 | 0.00 | 0.771 |
Normalised SIII | −0.07 | 0.01 | 0.623 | 0.06 | 0.00 | 0.629 |
KPIv | 0.29 | 0.08 | 0.04 | 0.124 | 0.02 | 0.325 |
CII1 | 0.68 | 0.47 | <0.001 | 0.06 | 0.00 | 0.620 |
CII2 | 0.66 | 0.44 | <0.001 | 0.11 | 0.01 | 0.389 |
Data are presented as Pearson correlation coefficients (r) and coefficients of determination (r2). VCap: volumetric capnography; SII: slope of phase II; SIII: slope of phase III; KPIv: capnographic index; CII: capnographic inhomogeneity index. #: t-test.